Covered recipient · General Payments record
ISABEL BETANCOURT
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$12,311.06
- Reported across 252 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $3,227.67 | 67 |
| Travel and Lodging | $1,060.07 | 2 |
| Consulting Fee | $900.00 | 1 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14.29 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $1,761.03 | 10 |
| Teleflex LLC | $1,393.60 | 12 |
| Axonics Modulation Technologies, Inc. | $358.77 | 8 |
| BIOPROTECT MEDICAL, INC. | $236.78 | 1 |
| Antares Pharma, Inc. | $205.33 | 6 |
| Endo USA, Inc. | $194.81 | 4 |
| ABBVIE INC. | $126.82 | 3 |
| Gilead Sciences, Inc. | $124.97 | 1 |
| Laborie Medical Technologies Corp. | $111.27 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $91.57 | 1 |
| Sumitomo Pharma America, Inc. | $82.97 | 3 |
| Astellas Pharma US Inc | $81.65 | 3 |
| ConvaTec Inc. | $70.59 | 3 |
| COLOPLAST CORP | $63.34 | 3 |
| Dendreon Pharmaceuticals LLC | $58.17 | 2 |
| TOLMAR, INC. | $46.14 | 2 |
| UROGEN PHARMA, INC. | $30.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.72 | 1 |
| Myriad Genetic Laboratories, Inc. | $26.82 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $26.16 | 1 |
| LANTHEUS MEDICAL IMAGING, INC. | $21.15 | 1 |
| PROCEPT BioRobotics Corporation | $20.94 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $20.71 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $19.31 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (71)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.